GNOLF SEC-arkiveringar - Genoil Inc.- Årsredovisning, Fullmaktsutlåtande, prospekt

Grundläggande statistik

CIK

1261002

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Genoil Inc.

SEC Filings (Chronological Order)

Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.

August 14, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending June 30, 2025 Commission File Number 0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending June 30, 2025 Commission File Number 000-50766 GENOIL INC. (Translation of registrant’s name into English) One Rockefeller Plaza 11th Floor, New York, NY 10020 (Address of principal execut
August 14, 2025	EX-99.1	GENOIL INC. June 30, 2025 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. June 30, 2025 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of June 30, 2025, and December 31, 2024 F-3 Consolidated Statements of Operations for the three and six months ended June 30, 2025 and June 30, 2024 F-4 Consolidated Statements of Stockholders’ Deficit for the three and si
June 2, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending March 31, 2025 Commission File Number UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending March 31, 2025 Commission File Number 000-50766 GENOIL INC. (Translation of registrant’s name into English) One Rockefeller Plaza 11th Floor, New York, NY 10020 (Address of principal execu
June 2, 2025	EX-99.1	GENOIL INC. March 31, 2025 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. March 31, 2025 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm Consolidated Balance Sheets as of March 31, 2025, and December 31, 2024 F-2 Consolidated Statements of Operations for the three months ended March 31, 2025 and March 31, 2024 F-3 Consolidated Statements of Stockholders’ Deficit for the three mont
May 1, 2025	EX-13.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2022
May 1, 2025	EX-15.1	GENOIL INC. December 31, 2024 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 15.1 GENOIL INC. December 31, 2024 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2024, and December 31, 2023 F-5 Consolidated Statements of Operations for the years ended December 31, 2024, and December 31, 2023 F-6 Consolidated Statements of Stockholders’ Deficit for the
May 1, 2025	EX-14.1	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F to the Annual Report of Genoil Inc. (the “Company”) of our report dated April 30, 2025 relating to the consolidated financial statements of the Company for the years ended December 31, 2024. /s/ HHL LLP New York, New York April 30, 2025
May 1, 2025	EX-12.1	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
May 1, 2025	20-F/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F OMB APPROVAL OMB Number: 3235-0288 Expires: Dec. 31, 2025 Estimated average burden hours per response..2628.16 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OFTHE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OFTHE SECURITIES EXCHANGE ACT OF 1934 For the fisc
April 30, 2025	EX-12.1	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
April 30, 2025	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F OMB APPROVAL OMB Number: 3235-0288 Expires: Dec. 31, 2025 Estimated average burden hours per response..2628.16 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OFTHE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OFTHE SECURITIES EXCHANGE ACT OF 1934 For the fisc
April 30, 2025	EX-13.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2022
April 30, 2025	EX-15.1	GENOIL INC. December 31, 2024 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 15.1 GENOIL INC. December 31, 2024 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2024, and December 31, 2023 F-5 Consolidated Statements of Operations for the years ended December 31, 2024, and December 31, 2023 F-6 Consolidated Statements of Stockholders’ Deficit for the
April 30, 2025	EX-14.1	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F to the Annual Report of Genoil Inc. (the “Company”) of our report dated April 30, 2025 relating to the consolidated financial statements of the Company for the years ended December 31, 2024. /s/ HHL LLP New York, New York April 30, 2025
April 24, 2025	EX-16.1	April 23, 2025 EXHIBIT 16.1 April 23, 2025 U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Ladies and Gentlemen: We were previously principal accountant for Genoil, Inc. an Alberta Canada corporation (the “Company”). We have read the disclosures under the paragraph entitled “Changes in Registrant’s Certifying Accountant” in the Company’s current report on Form 6-K, dated April 22, 2
April 24, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2025 Commission File Number 000-50766 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2025 Commission File Number 000-50766 GENOIL INC. (Translation of registrant’s name into English) One Rockefeller Plaza 11th Floor, New York, NY 10020 (Address of principal executive offi
November 19, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Period ending September 30, 2024 Commission File Num UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Period ending September 30, 2024 Commission File Number 000-50766 GENOIL INC. (Translation of registrant’s name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Ind
November 19, 2024	EX-99.1	GENOIL INC. September 30, 2024 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. September 30, 2024 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023 F-2 Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and September 30, 2023 F-3 Consolidated Statements of Stockholders’ Deficit for the three and nine months ended September 30, 2
August 15, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Period ending June 30, 2024 Commission File Number 0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Period ending June 30, 2024 Commission File Number 000-50766 GENOIL INC. (Translation of registrant’s name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Indicate
August 15, 2024	EX-99.1	GENOIL INC. June 30, 2024 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. June 30, 2024 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 F-3 Consolidated Statements of Operations for the three and six months ended June 30, 2024 and June 30, 2023 F- Consolidated Statements of Stockholders’ Deficit for the three and six months ended June 30, 2024 and June 30, 2023 F-5 Co
May 28, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Period ending March 31, 2024 Commission File Number UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Period ending March 31, 2024 Commission File Number 000-50766 GENOIL INC. (Translation of registrant’s name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Indicat
May 28, 2024	EX-99.1	GENOIL INC. March 31, 2024 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. March 31, 2024 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 F-2 Consolidated Statements of Operations for the three months ended March 31, 2024 and March 31, 2023 F-3 Consolidated Statements of Stockholders’ Deficit for the three months
May 16, 2024	EX-13.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2022
May 16, 2024	EX-13.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2022
May 16, 2024	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F OMB APPROVAL OMB Number: 3235-0288 Expires: Dec. 31, 2025 Estimated average burden hours per response..2628.16 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OFTHE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OFTHE SECURITIES EXCHANGE ACT OF 1934 For the fisc
May 16, 2024	EX-15.1	GENOIL INC. December 31, 2023 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 15.1 GENOIL INC. December 31, 2023 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm (PCAOB ID: 822) F-2 Consolidated Balance Sheets as of December 31, 2023, December 31, 2022 and December 31, 2021 F-4 Consolidated Statements of Operations for the years ended December 31, 2023, December 31, 2022 and December 31, 2021 F-5 Conso
May 16, 2024	EX-15.1	GENOIL INC. December 31, 2023 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 15.1 GENOIL INC. December 31, 2023 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2023, December 31, 2022 and December 31, 2021 F-4 Consolidated Statements of Operations for the years ended December 31, 2023, December 31, 2022 and December 31, 2021 F-5 Consolidated Statemen
May 16, 2024	EX-12.1	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
May 16, 2024	EX-14.1	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F to the Annual Report of Genoil Inc. (the “Company”) of our report dated May 15, 2024 relating to the consolidated financial statements of the Company for the years ended December 31, 2023, December 31, 2022, and December 31, 2021 included in this Form 20-F. /s/ Michael T. Stud
May 16, 2024	EX-14.1	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F to the Annual Report of Genoil Inc. (the “Company”) of our report dated May 15, 2024 relating to the consolidated financial statements of the Company for the years ended December 31, 2023, December 31, 2022, and December 31, 2021 included in this Form 20-F. /s/ Michael T. Stud
May 16, 2024	EX-12.2	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
May 16, 2024	20-F/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A OMB APPROVAL OMB Number: 3235-0288 Expires: Dec. 31, 2025 Estimated average burden hours per response..2628.16 (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OFTHE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OFTHE SECURITIES EXCHANGE ACT OF 1934 For the fi
May 16, 2024	EX-12.2	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
May 16, 2024	EX-13.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2022
May 16, 2024	EX-12.1	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
May 16, 2024	EX-13.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2022
April 29, 2024	NT 20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response.......2.50 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transiti
November 13, 2023	EX-99.1	GENOIL INC. September 30, 2023 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. September 30, 2023 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022 F-2 Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and September 30, 2022 F-3 Consolidated Statements of Stockholders’ Equity (Deficit) for the three and nine months ended Septem
November 13, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Period ending September 30, 2023 Commission File Num UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Period ending September 30, 2023 Commission File Number 000-50766 GENOIL INC. (Translation of registrant’s name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Ind
August 24, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending June 30, 2023 Commission File Number 0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending June 30, 2023 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Indicate
August 24, 2023	EX-99.1	GENOIL INC. June 30, 2023 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. June 30, 2023 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022 F-2 Consolidated Statements of Operations for the three and six months ended June 30, 2023 and June 30, 2022 F-3 Consolidated Statements of Stockholders’ Deficit for the three and six months ended June 30, 2023 and June 30, 2022 F-4 C
May 23, 2023	EX-99.1	GENOIL INC. March 31, 2023 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. March 31, 2023 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 F-2 Consolidated Statements of Operations for the three months ended March 31, 2023 and March 31, 2022 F-3 Consolidated Statements of Stockholders’ Deficit for the three months ended March 31, 2023 and March 31, 2022 F-4 Consolidate
May 23, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending March 31, 2023 Commission File Number UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending March 31, 2023 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Indicat
May 2, 2023	EX-12.2	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
May 2, 2023	EX-13.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2022
May 2, 2023	EX-14.1	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F Annual Report of Genoil Inc. (the “Company”) of our report dated April 27, 2023 relating to the consolidated financial statements of the Company for the years ended December 31, 2022, December 31, 2021, and December 31, 2020 included in this Form 20-F. /s/ Michael T. Studer CP
May 2, 2023	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 OMB APPROVAL OMB Number: 3235-0288 Expires: Dec. 31, 2025 Estimated average burden hours per response..2628.16 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OFTHE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OFTHE SECURITIES EXCHANGE ACT OF 1934 For the fisc
May 2, 2023	EX-15.1	GENOIL INC. December 31, 2022 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 15.1 GENOIL INC. December 31, 2022 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2022, December 31, 2021 and December 31, 2020 F-3 Consolidated Statements of Operations for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 F-4 Consolidated Statemen
May 2, 2023	EX-12.1	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
May 2, 2023	EX-13.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2022
April 26, 2023	EX-13.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2021
April 26, 2023	EX-14.1	Independent Auditor’s Consent of Michael T. Studer CPA P.C. EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F/A-1 to the Annual Report of Genoil Inc. (the “Company”) of our report dated May 18, 2022 (except as to the December 31, 2021 and year ended December 31, 2021 section of Note 12, which is dated as of April 6, 2023) relating to the consolidated financial statements of the Compan
April 26, 2023	20-F/A	OMB APPROVAL OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 OMB Number: 3235-0288 Expires: October 31, 2022 Estimated average burden hours per response..2629.68 AMENDMENT NO. 1 TO FORM 20-F/A (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHAN
April 26, 2023	EX-12.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
April 26, 2023	EX-15.1	GENOIL INC. December 31, 2021 FORM 20-F / A-1 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 15.1 GENOIL INC. December 31, 2021 FORM 20-F / A-1 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2021, December 31, 2020, and December 31, 2019 F-3 Consolidated Statements of Operations for the years ended December 31, 2021, December 31, 2020 and December 31, 2019 F-4 Consolidated S
April 26, 2023	EX-13.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Pursuant to 18 U.S.C. SECTION 1350 EXHIBIT 13.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2021
April 26, 2023	EX-12.2	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
April 24, 2023	EX-15.1	GENOIL INC. December 31, 2021 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 15.1 GENOIL INC. December 31, 2021 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm PCAOB Firm ID 822 F-2 Consolidated Balance Sheets as of December 31, 2021, December 31, 2020, and December 31, 2019 F-3 Consolidated Statements of Operations for the years ended December 31, 2021, December 31, 2020 and December 31, 2019 F-4 Co
April 24, 2023	EX-13.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Pursuant to 18 U.S.C. SECTION 1350 EXHIBIT 13.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2021
April 24, 2023	EX-12.2	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
April 24, 2023	EX-12.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
April 24, 2023	EX-13.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2021
April 24, 2023	20-F/A	OMB APPROVAL OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 OMB Number: 3235-0288 Expires: October 31, 2022 Estimated average burden hours per response..2629.68 FORM 20-F/A (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For
April 24, 2023	EX-14.1	Independent Auditor’s Consent of Michael T. Studer CPA P.C. EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F Annual Report of Genoil Inc. (the “Company”) of our report dated May 18, 2022 relating to the consolidated financial statements of the Company for the years ended December 31, 2021, December 31, 2020, and December 31, 2019 included in this Form 20-F. /s/ Michael T. Studer CPA
November 10, 2022	EX-99.1	GENOIL INC. September 30, 2022 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. September 30, 2022 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021 F-2 Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and September 30, 2021 F-3 Consolidated Statements of Stockholders’ Deficit for the three and nine months ended September 30, 2
November 10, 2022	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending September 30, 2022 Commission File Num UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending September 30, 2022 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Ind
August 10, 2022	EX-99.1	June 30, 2022 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. June 30, 2022 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 F-2 Consolidated Statements of Operations for the three and six months ended June 30, 2022 and June 30, 2021 F-3 Consolidated Statements of Stockholders’ Deficit for the three and six months ended June 30, 2022 and June 30, 2021 F-4 C
August 10, 2022	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending June 30, 2022 Commission File Number 0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending June 30, 2022 Commission File Number 000-50766 GENOIL INC. (Translation of registrant’s name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Indicate
July 5, 2022	EX-99.1	GENOIL INC. March 31, 2022 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EX-99.1 2 gnolfex991.htm FINANCIAL STATEMENTS EXHIBIT 99.1 GENOIL INC. March 31, 2022 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021 F-2 Consolidated Statements of Operations for the three months ended March 31, 2022 and March 31, 2021 F-3 Consolidated Statements of Stockholders’ Deficit for the three months ended Mar
July 5, 2022	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending March 31, 2022 Commission File Number 6-K 1 gnolf6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending March 31, 2022 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of principa
May 20, 2022	EX-13.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Pursuant to 18 U.S.C. SECTION 1350 EXHIBIT 13.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2021
May 20, 2022	EX-13.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EXHIBIT 13.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2021
May 20, 2022	EX-14.1	Independent Auditor’s Consent of Michael T. Studer CPA P.C. EX-14.1 2 gnolfex141.htm CONSENT EXHIBIT 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F Annual Report of Genoil Inc. (the “Company”) of our report dated May 18, 2022 relating to the consolidated financial statements of the Company for the years ended December 31, 2021, December 31, 2020, and December 31, 2019 included in this Form
May 20, 2022	EX-12.2	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT EXHIBIT 12.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
May 20, 2022	20-F	OMB APPROVAL OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 OMB Number: 3235-0288 Expires: October 31, 2022 Estimated average burden hours per response..2629.68 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For th
May 20, 2022	EX-15.1	GENOIL INC. December 31, 2021 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 15.1 GENOIL INC. December 31, 2021 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm PCAOB Firm ID 822 F-2 Consolidated Balance Sheets as of December 31, 2021, December 31, 2020, and December 31, 2019 F-3 Consolidated Statements of Operations for the years ended December 31, 2021, December 31, 2020 and December 31, 2019 F-4 Co
May 20, 2022	EX-12.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 EXHIBIT 12.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
April 29, 2022	NT 20-F	OMB APPROVAL NT 20-F 1 gnolfnt20f.htm NT 20-F OMB APPROVAL OMB Number: 3235-0058 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Expires: April 30, 2022 Estimated average burden hours per response.......2.50 FORM 12b-25 SEC FILE NUMBER CUSIP NUMBER NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☑ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period En
April 29, 2022	NT 20-F/A	OMB APPROVAL NT 20-F/A 1 gnolfnt20f.htm NT 20-F/A OMB APPROVAL OMB Number: 3235-0058 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Expires: April 30, 2022 Estimated average burden hours per response.......2.50 FORM 12b-25 (Amendment No. 1) SEC FILE NUMBER CUSIP NUMBER NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☑ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Fo
November 18, 2021	EX-99.2	Management’s Discussion and Analysis September 30, 2021 EX-99.2 3 gnolfex992.htm MANAGEMENT'S DISCUSSION AND ANALYSIS Exhibit 99.2 Management’s Discussion and Analysis September 30, 2021 Management’s Discussion and Analysis Dated as of November 11, 2021 This Management’s Discussion and Analysis (MD&A) is dated November 11, 2021 and should be read in conjunction with the unaudited financial statements for the quarters ended September 30, 2021 and 2020.
November 18, 2021	EX-99.3	Form 52-109FV2 Exhibit 99.3 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances un
November 18, 2021	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending September 30, 2021 Commission File Num UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending September 30, 2021 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Ind
November 18, 2021	EX-99.1	GENOIL INC. September 30, 2021 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EX-99.1 2 gnolfex991.htm FINANCIAL STATEMENTS Exhibit 99.1 GENOIL INC. September 30, 2021 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020 F-2 Consolidated Statements of Operations for the three and nine months ended September 30, 2021 and 2020 F-3 Consolidated Statements of Stockholders’ Deficit for the three and n
September 8, 2021	EX-99.3	EX-99.3 Exhibit 99.3
September 8, 2021	EX-99.1	GENOIL INC. June 30, 2021 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EX-99.1 2 gnofex991.htm FINANCIAL STATEMENTS Exhibit 99.1 GENOIL INC. June 30, 2021 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of June 30, 2021 and December 31, 2020 F-2 Consolidated Statements of Operations for the three and six months ended June 30, 2021 and 2020 F-3 Consolidated Statements of Stockholders’ Deficit for the three and six months ended J
September 8, 2021	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending June 30, 2021 Commission File Number 0 6-K 1 gnolf6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending June 30, 2021 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of principal
September 8, 2021	EX-99.2	Management’s Discussion and Analysis June 30, 2021 Exhibit 99.3 Management?s Discussion and Analysis June 30, 2021 Management?s Discussion and Analysis Dated as of August 20, 2021 This Management?s Discussion and Analysis (MD&A) is dated August 20, 2021 and should be read in conjunction with the unaudited financial statements for the quarters ended June 30, 2021 and 2020. This and other information relating to Genoil Inc. are available at www.sec.
August 25, 2021	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended June 30, 2021 Commission File Number 00 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended June 30, 2021 Commission File Number 000-50766 GENOIL INC. (Translation of registrant?s name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Indicate
June 14, 2021	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending March 31, 2021 Commission File Number 6-K 1 gnolf6k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ending March 31, 2021 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of pr
June 14, 2021	EX-99.2	Management’s Discussion and Analysis March 31, 2021 EX-99.2 3 gnolfex992.htm MANAGEMENT'S DISCUSSION AND ANALYSIS Exhibit 99.2 Management’s Discussion and Analysis March 31, 2021 Management’s Discussion and Analysis Dated as of June 11, 2021 This Management’s Discussion and Analysis (MD&A) is dated June 11, 2021 and should be read in conjunction with the unaudited financial statements for the quarters ended March 31, 2021 and 2020. This and other i
June 14, 2021	EX-99.3	EX-99.3 Exhibit 99.3
June 14, 2021	EX-99.4	EX-99.4 Exhibit 99.4
June 14, 2021	EX-99.1	GENOIL INC. March 31, 2021 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EX-99.1 2 genolex991.htm FINANCIAL STATEMENTS Exhibit 99.1 GENOIL INC. March 31, 2021 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of March 31, 2021 and December 31, 2020 F-2 Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020 F-3 Consolidated Statements of Stockholders’ Deficit for the three months ended March 31, 202
June 7, 2021	6-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDNENT NO. 1 TO FORM 6-K Filed May 3, 2021 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the one year ending UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDNENT NO. 1 TO FORM 6-K Filed May 3, 2021 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the one year ending December 31, 2020 Commission File Number 000-50766 GENOIL INC. (Translation of registrant?s name into English) One Rockefeller Plaza 11th Floor (Addr
May 14, 2021	EX-15.1	Audited Consolidated Financial Statements December 31, 2021 GENOIL INC. December 31, 2020 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2020, December 31, 2019, and December 31, 2018 F-3 Consolidated Statements of Operations for the years ended December 31, 2020, December 31, 2019 and December 31, 2018 F-4 Consolidated Statements of Stockh
May 14, 2021	EX-12.1	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1.
May 14, 2021	20-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F 20-F 1 gnolf20f.htm 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR X ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal years ended December 31, 2018, 2019 and 2020 OR TRANSITION REPORT PURSUANT TO SECT
May 14, 2021	EX-13.1	CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT CERTIFICATION OF THE CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1.
May 14, 2021	EX-13.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.
May 14, 2021	EX-14.1	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F Annual Report of Genoil Inc.
May 14, 2021	EX-12.2	CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.
May 3, 2021	EX-99.1	December 31, 2020 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.1 GENOIL INC. December 31, 2020 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2020, December 31, 2019, and December 31, 2018 F-3 Consolidated Statements of Operations for the years ended December 31, 2020, December 31, 2019 and December 31, 2018 F-4 Consolidated Stateme
May 3, 2021	EX-99.3	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT Exhibit 99.3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
May 3, 2021	EX-99.4	CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT EX-99.4 5 gnolfex994.htm CERTIFICATION Exhibit 99.4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Compa
May 3, 2021	EX-99.2	Management’s Discussion and Analysis December 31, 2020 EX-99.2 3 gnolfex992.htm MANAGEMENT'S DISCUSSION AND ANALYSIS Exhibit 99.2 Management’s Discussion and Analysis December 31, 2020 Management’s Discussion and Analysis Dated as of April 30, 2021 This Management’s Discussion and Analysis (MD&A) is dated April 30, 2021 and should be read in conjunction with the audited financial statements for the year ended December 31, 2020. This and other informat
May 3, 2021	6-K	Current Report of Foreign Issuer - FORM 6-K 6-K 1 f6k111417.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the one year ending December 31, 2020 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of p
May 3, 2021	NT 20-F	- NT 20-F NT 20-F 1 gnolfnt20-f.htm NT 20-F OMB APPROVAL OMB Number: 3235-0058 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Expires: February 28, 2022 Estimated average burden hours per response.......2.50 FORM 12b-25 SEC FILE NUMBER CUSIP NUMBER NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☑ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Perio
April 28, 2021	EX-13.1	CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Exhibit 13.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906 OF THE SARBANES-OXLEY ACT Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Genoil Inc. (the “Company”) hereby certifies, to such officer’s knowledge that: 1. The accompanying Annual Report on Form 20-F of the Company for the year ended December 31, 2020
April 28, 2021	EX-12.1	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT Exhibit 12.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, David Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
April 28, 2021	20-F/A	- 20-F/A OMB APPROVAL UNITED STATES OMB Number 3235-0288 SECURITIES AND EXCHANGE COMMISSION Expires: July 31, 2021 WASHINGTON, D.
April 28, 2021	EX-15.1	GENOIL INC. December 31, 2019 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Exhibit 15.1 GENOIL INC. December 31, 2019 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2019, 2018, and 2017 F-3 Consolidated Statements of Operations for the years ended December 31, 2019, 2018, and 2017 F-4 Consolidated Statements of Stockholders’ Deficit for the years ended De
April 28, 2021	EX-14.1	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EX-14.1 4 gnolfex141.htm EX-14.1 Exhibit 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F Annual Report of Genoil Inc. (the “Company”) of my report dated June 30, 2020 relating to the consolidated financial statements of the Company for the years ended December 31, 2019, 2018, and 2017 included in this Form 20-F. /s/ Michael T. Stud
November 16, 2020	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.3 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, David Lifschultz (i) the certifying officer, Chief Financial Officer & CEO (iii) Genoil Inc, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Genoil Inc (the “issuer”) for the interim period ended September 30, 2020. 2.
November 16, 2020	EX-99.1	GENOIL INC. September 30, 2020 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS GENOIL INC. September 30, 2020 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019 F-2 Consolidated Statements of Operations for the three and nine months ended September 30, 2020 and 2019 F-3 Consolidated Statements of Stockholders’ Deficit for the three and nine months ended September 30, 2020 and 2019 F-4 Consolidat
November 16, 2020	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended September 30, 2020 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Indi
November 16, 2020	EX-99.2	Management’s Discussion and Analysis September 30, 2020 Exhibit 99.2 Management’s Discussion and Analysis September 30, 2020 Management’s Discussion and Analysis Dated as of November 13, 2020 This Management’s Discussion and Analysis (MD&A) is dated November 13, 2020 and should be read in conjunction with the audited financial statements for the quarter ended September 30, 2020. This and other information relating to Genoil Inc. are available at www.se
September 29, 2020	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended March 31, 2020 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Indicate
September 29, 2020	EX-99.1	GENOIL INC. March 31, 2020 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS EX-99.1 2 exhex991.htm FINANCIAL STATEMENTS Exhibit 99.1 GENOIL INC. March 31, 2020 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019 F-2 Consolidated Statements of Operations for the three months ended March 31, 2020 and 2019 F-3 Consolidated Statements of Stockholders’ Deficit for the three months ended March 31, 2020
September 29, 2020	EX-99.2	Management’s Discussion and Analysis June 30, 2020 Exhibit 99.2 Management’s Discussion and Analysis June 30, 2020 Management’s Discussion and Analysis Dated as of September 29, 2020 This Management’s Discussion and Analysis (MD&A) is dated September 29, 2020, and should be read in conjunction with the audited financial statements for the quarter ended June 30, 2020. This and other information relating to Genoil Inc. are available at www.sec.gov.
September 29, 2020	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.3 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, David Lifschultz (i) the certifying officer, Chief Financial Officer & CEO (iii) Genoil Inc, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Genoil Inc (the “issuer”) for the interim period ended March 31, 2020. 2. No
September 29, 2020	EX-99.2	Management’s Discussion and Analysis March 31, 2020 EX-99.2 3 exh992.htm MANAGEMENT'S DISCUSSION AND ANALYSIS Exhibit 99.2 Management’s Discussion and Analysis March 31, 2020 Management’s Discussion and Analysis Dated as of September 29, 2020 This Management’s Discussion and Analysis (MD&A) is dated September 29, 2020, and should be read in conjunction with the audited financial statements for the quarter ended March 31, 2020. This and other inform
September 29, 2020	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.3 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, David Lifschultz (i) the certifying officer, Chief Financial Officer & CEO (iii) Genoil Inc, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Genoil Inc (the “issuer”) for the interim period ended June 30, 2020. 2. No m
September 29, 2020	EX-99.1	GENOIL INC. June 30, 2020 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.1 GENOIL INC. June 30, 2020 FORM 6-K INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019 F-2 Consolidated Statements of Operations for the three and six months ended June 30, 2020 and 2019 F-3 Consolidated Statements of Stockholders’ Deficit for the three and six months ended June 30, 2020 and 2019 F-4 Consolidated Statem
September 29, 2020	6-K	Current Report of Foreign Issuer - FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended June 30, 2020 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor (Address of principal executive office) Indicate
July 1, 2020	EX-15.1	GENOIL INC. December 31, 2019 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Exhibit 15.1 GENOIL INC. December 31, 2019 FORM 20-F INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets as of December 31, 2019, 2018, and 2017 F-3 Consolidated Statements of Operations for the years ended December 31, 2019, 2018, and 2017 F-4 Consolidated Statements of Stockholders’ Deficit for the years ended De
July 1, 2020	20-F	- ANNUAL REPORT OMB APPROVAL UNITED STATES OMB Number 3235-0288 SECURITIES AND EXCHANGE COMMISSION Expires: July 31, 2021 WASHINGTON, D.
July 1, 2020	EX-14.1	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 14.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the inclusion in this Form 20-F Annual Report of Genoil Inc. (the “Company”) of my report dated June 30, 2020 relating to the consolidated financial statements of the Company for the years ended December 31, 2019, 2018, and 2017 included in this Form 20-F. /s/ Michael T. Studer CPA P.C. Michael T. Studer CPA
April 3, 2018	NT 20-F	GNOLF / Genoil Inc. NT 20-F OMB APPROVAL OMB Number: 3235-0058 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
April 2, 2018	NT 10-K	GNOLF / Genoil Inc. NT 10-K Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
November 14, 2017	EX-99.1	GENOIL INC. GENOIL, INC. Consolidated Balance Sheets ASSETS September 30, December 31, 2017 2016 (Unaudited) CURRENT ASSETS Cash and cash equivalents $ 28,313 $ 2,325 Due from related-parties 215,547 870,242 Total Current Assets 243,860 872,567 PROPERTY AND EQUIPMENT, net 102,624 107,094 OTHER ASSETS Intangible assets 35,456 39,713 TOTAL ASSETS $ 381,940 $ 1,019,374 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRE
November 14, 2017	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.3 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada?s changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on
November 14, 2017	EX-99.2	Management’s Discussion and Analysis September 30, 2017 Management?s Discussion and Analysis September 30, 2017 Management?s Discussion and Analysis Dated as of November 13, 2017 This Management?s Discussion and Analysis (MD&A) is dated November 13, 2017, and should be read in conjunction with the audited financial statements for the year ended December 31, 2016.
November 14, 2017	6-K	GNOLF / Genoil Inc. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended September 30, 2017 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal exe
August 15, 2017	EX-99.4	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.4 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada?s changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on
August 15, 2017	EX-99.1	GENOIL INC. EX-99.1 2 exh991.htm EXHIBIT 99.1 Exhibit 99.1 GENOIL, INC. Consolidated Balance Sheets ASSETS June 30, December 31, 2017 2016 (Unaudited) CURRENT ASSETS Cash and cash equivalents $ 11,242 $ 2,325 Due from related-parties 264,521 870,242 Total Current Assets 275,763 872,567 PROPERTY AND EQUIPMENT, net 104,114 107,094 OTHER ASSETS Intangible assets 36,875 39,713 TOTAL ASSETS $ 416,752 $ 1,019,374 L
August 15, 2017	6-K	Genoil FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended June 30, 2017 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executiv
August 15, 2017	EX-99.2	Management’s Discussion and Analysis Exhibit 99.2 Management?s Discussion and Analysis June 30, 2017 Management?s Discussion and Analysis Dated as of August 14, 2017 This Management?s Discussion and Analysis (MD&A) is dated August 14, 2017, and should be read in conjunction with the audited financial statements for the year ended December 31, 2016. This and other information relating to Genoil Inc. are available on SEDAR at www.sedar
August 15, 2017	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate EX-99.3 4 exh993.htm EXHIBIT 99.3 Exhibit 99.3 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada’s changeover to IFRS. The amendments apply for financial periods relati
May 16, 2017	6-K/A	Genoil GENOIL, INC. 6-K/A (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Amendment No. 1 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended March 31, 2017 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of
May 16, 2017	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.3 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada?s changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on
May 16, 2017	EX-99.4	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.4 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada?s changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on
May 16, 2017	EX-99.2	Management’s Discussion and Analysis March 31, 2017 Exhibit 99.2 Management?s Discussion and Analysis March 31, 2017 Management?s Discussion and Analysis Dated as of May 15, 2017 This Management?s Discussion and Analysis (MD&A) is dated May 15, 2016, and should be read in conjunction with the audited financial statements for the year ended December 31, 2016. This and other information relating to Genoil Inc. are available on SEDAR at www.sedar.com.
May 16, 2017	EX-99.1	GENOIL, INC. Exhibit 99.1 GENOIL, INC. Consolidated Balance Sheets ASSETS March 31, December 31, 2017 2016 (Unaudited) CURRENT ASSETS Cash and cash equivalents $ 21,610 $ 2,325 Due from related-parties 488,424 870,242 Total Current Assets 510,034 872,567 PROPERTY AND EQUIPMENT, net 105,604 107,094 OTHER ASSETS Intangible assets 38,294 39,713 TOTAL ASSETS $ 653,932 $ 1,019,374 LIABILITIES AND STOCKHOLDERS' DEFI
May 16, 2017	6-K	Genoil GENOIL INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended March 31, 2017 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executi
May 16, 2017	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.3 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada?s changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on
May 16, 2017	EX-99.4	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.4 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada?s changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on
May 16, 2017	EX-99.2	Management’s Discussion and Analysis March 31, 2017 Exhibit 99.2 Management?s Discussion and Analysis March 31, 2017 Management?s Discussion and Analysis Dated as of May 15, 2017 This Management?s Discussion and Analysis (MD&A) is dated May 15, 2016, and should be read in conjunction with the audited financial statements for the year ended December 31, 2016. This and other information relating to Genoil Inc. are available on SEDAR at www.sedar.com.
May 16, 2017	EX-99.1	GENOIL, INC. Exhibit 99.1 GENOIL, INC. Consolidated Balance Sheets ASSETS March 31, December 31, 2017 2016 (Unaudited) CURRENT ASSETS Cash and cash equivalents $ 21,610 $ 2,325 Due from related-parties 488,424 870,242 Total Current Assets 510,034 872,567 PROPERTY AND EQUIPMENT, net 105,604 107,094 OTHER ASSETS Intangible assets 38,294 39,713 TOTAL ASSETS $ 653,932 $ 1,019,374 LIABILITIES AND STOCKHOLDERS' DEFI
March 2, 2017	EX-12.1	CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 Certification of Chief Executive Officer, Chief Financial and Accounting Officer Exhibit 12.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 Certification of Chief Executive Officer, Chief Financial and Accounting Officer I, David K. Lifschultz, certify that: 1. I have reviewed this Annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact n
March 2, 2017	EX-14.1	Pinaki & Associates LLC Certified Public Accountants 625 Barksdale Rd., Ste# 113 Newark, DE 19711 Phone: 408-896-4405 \| [email protected] Exhibit 14.1 Pinaki & Associates LLC Certified Public Accountants 625 Barksdale Rd., Ste# 113 Newark, DE 19711 Phone: 408-896-4405 \| [email protected] To The Board of Directors Genoil Inc One Rockefeller Center, 11th Floor New York, NY 10020 We have audited the accompanying consolidated balance sheets of Genoil Inc. and subsidiaries as of December 31, 2016, 2015 and 2014 and the rela
March 2, 2017	EX-13.1	Certification of Chief Executive Officer and Chief Financial and Accounting Officer Pursuant to 18 U.S.C. SECTION 1350 Exhibit 13.1 Certification of Chief Executive Officer and Chief Financial and Accounting Officer Pursuant to 18 U.S.C. SECTION 1350 In connection with the Annual Report of Genoil Inc., (the ?Company?) on Form 20-F for the period ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), I, David K. Lifschultz, Chief Executive Officer and Chief F
March 2, 2017	EX-15.1	GENOIL, INC. CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2016, 2015 AND 2014 Exhibit 15.1 GENOIL, INC. CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2016, 2015 AND 2014 GENOIL, INC. Consolidated Balance Sheets ASSETS December 31, December 31, December 31, 2016 2015 2014 CURRENT ASSETS Cash and cash equivalents $ 2,325 $ - $ - Prepaid expenses and deposits - - 679 Due from related-parties 870,242 430,302 262,495 Total Current Assets 872,567 430,302 263,174 PROPERTY AND EQU
March 2, 2017	20-F	Genoil GENOIL INC. 20-F OMB APPROVAL UNITED STATES OMB Number 3235-0288 SECURITIES AND EXCHANGE COMMISSION Expires: May 31, 2017 WASHINGTON, D.
February 27, 2017	6-K	Genoil GENOIL INC 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended February 23, 2017 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal exec
February 27, 2017	EX-99.1	Genoil releases 2016 financial results Exhibit 99.1 PRESS RELEASE Genoil releases 2016 financial results Calgary, Alberta ? February 23 rd 2017 ? Genoil Inc. (GNOLF), the publicly traded clean technology engineering company for the petroleum industry, today announced that it has filed its annual financial returns for 2016. The return announces that all non-related third party debt has been paid off, and in addition all the holders of t
February 23, 2017	EX-99.2	Pinaki & Associates LLC Certified Public Accountants 625 Barksdale Rd., Ste# 113 Newark, DE 19711 Phone: 408-896-4405 \| [email protected] Exhibit 99.2 Pinaki & Associates LLC Certified Public Accountants 625 Barksdale Rd., Ste# 113 Newark, DE 19711 Phone: 408-896-4405 \| [email protected] To The Board of Directors Genoil Inc One Rockefeller Center, 11th Floor New York, NY 10020 We have audited the accompanying consolidated balance sheets of Genoil Inc. and subsidiaries as of December 31, 2016, and the related consolidat
February 23, 2017	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended December 31, 2016 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal exec
February 23, 2017	EX-99.3	Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate Exhibit 99.3 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, David Lifschultz, Chief Executive Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the "annual f
February 23, 2017	EX-99.1	Management's Discussion and Analysis December 31, 2016 Exhibit 99.1 Management's Discussion and Analysis December 31, 2016 Management's Discussion and Analysis Dated as of February 7, 2017 This Management's Discussion and Analysis (MD&A) is dated February 17, 2016, and should be read in conjunction with the audited financial statements for the year ended December 31, 2016. This and other information relating to Genoil Inc. are available on SEDAR at ww
February 23, 2017	EX-99.4	Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate Exhibit 99.4 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, David Lifschultz, Chief Executive Officer and Acting Chief Financial Officer of Genoil Inc., certify the following in my capacity as Acting Chief Financial Officer: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents an
December 23, 2016	CORRESP	Genoil ESP c/o Suite 218, 1811 ? 4th Street SW Calgary , Alberta T2S 1W2, Canada December 22, 2016 Karl Hiller Branch Chief, Office of Natural Resources United States Securities and Exchange Commission Washington, D.
November 14, 2016	EX-99.2	Management’s Discussion and Analysis September 30, 2016 Exhibit 99.2 Management?s Discussion and Analysis September 30, 2016 Management?s Discussion and Analysis Dated as of November 10, 2016 This Management?s Discussion and Analysis (MD&A) is dated November 10, 2016, and should be read in conjunction with the audited financial statements for the quarter ended September 30, 2016. This and other information relating to Genoil Inc. are available on SEDAR
November 14, 2016	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate EX-99.3 4 exh993.htm EXHIBIT 99.3 Exhibit 99.3 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada’s changeover to IFRS. The amendments apply for financial periods relati
November 14, 2016	6-K	Genoil GENOIL INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the period ended September 30, 2016 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal exe
November 14, 2016	EX-99.1	GENOIL, INC. Exhibit 99.1 GENOIL, INC. Consolidated Balance Sheets ASSETS September 30, December 31, 2016 2015 (Unaudited) CURRENT ASSETS Cash and cash equivalents $ - $ - Due from related-parties 498,949 430,302 Total Current Assets 498,949 430,302 PROPERTY AND EQUIPMENT, net 108,584 111,796 OTHER ASSETS Intangible assets 41,132 45,389 TOTAL ASSETS $ 648,665 $ 587,487 LIABILITIES AND STOCKHOLDERS' DEFICIT CUR
October 13, 2016	CORRESP	Genoil ESP c/o Suite 218, 1811 - 4 th Street SW Calgary, Alberta T2S 1W2, Canada September 27, 2016 Via E-mail Karl Hiller Branch Chief, Office of Natural Resources United States Securities and Exchange Commission Washington, D.
August 17, 2016	EX-99.1	GENOIL, INC. Exhibit 99.1 GENOIL, INC. Consolidated Balance Sheets ASSETS June 30, December 31, 2016 2015 (Unaudited) CURRENT ASSETS Cash and cash equivalents $ - $ - Due from related-parties 551,262 430,302 Total Current Assets 551,262 430,302 PROPERTY AND EQUIPMENT, net 110,074 111,796 OTHER ASSETS Intangible assets 42,551 45,389 TOTAL ASSETS $ 703,887 $ 587,487 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT
August 17, 2016	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.3 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada's changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on
August 17, 2016	EX-99.2	Management's Discussion and Analysis June 30, 2015 Exhibit 99.2 Management's Discussion and Analysis June 30, 2015 Management's Discussion and Analysis Dated as of December 13, 2015 This Management's Discussion and Analysis (MD&A) is dated December 13, 2015, and should be read in conjunction with the audited financial statements for the quarter ended June 30, 2015. This and other information relating to Genoil Inc. are available on SEDAR at www.se
August 17, 2016	EX-99.4	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.4 Unofficial consolidation for financial years beginning on or after January 1, 2011 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada's changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on
August 17, 2016	6-K	Genoil GENOIL INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2016 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executive off
May 20, 2016	EX-99.2	Management's Discussion and Analysis December 31, 2015 Exhibit 99.2 Management's Discussion and Analysis December 31, 2015 Management's Discussion and Analysis Dated as of April 12, 2016 This Management's Discussion and Analysis (MD&A) is dated April 12, 2016, and should be read in conjunction with the audited financial statements for the year ended December 31, 2015. This and other information relating to Genoil Inc. are available on SEDAR at www.sed
May 20, 2016	EX-99.3	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.3 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada's changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on or after January 1, 2011. This document is for reference purposes only and is not
May 20, 2016	EX-99.4	Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Exhibit 99.4 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canada's changeover to IFRS. The amendments apply for financial periods relating to financial years beginning on or after January 1, 2011. This document is for reference purposes only and is not
May 20, 2016	6-K	Genoil GENOIL INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2016 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executive office
May 20, 2016	EX-99.1	GENOIL, INC. Exhibit 99.1 GENOIL, INC. Consolidated Balance Sheets ASSETS March 31, December 31, 2016 2015 CURRENT ASSETS Cash and cash equivalents $ - $ - Due from related-parties 455,477 430,302 Total Current Assets 455,477 430,302 PROPERTY AND EQUIPMENT, net 110,313 111,796 OTHER ASSETS Intangible assets 43,970 45,389 TOTAL ASSETS $ 609,760 $ 587,487 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES
May 10, 2016	EX-13.2	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 13.2 Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F of Genoil Inc. (the "Company") for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Brian Korney, Chief Financial Officer of the Co
May 10, 2016	20-F	Genoil GENOIL INC. 20-F OMB APPROVAL UNITED STATES OMB Number 3235-0288 SECURITIES AND EXCHANGE COMMISSION Expires: May 31, 2016 WASHINGTON, D.
May 10, 2016	EX-13.1	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 13.1 Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F of Genoil Inc. (the "Company") for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David K. Lifschultz, Chairman and Chief Executi
May 10, 2016	EX-14.1	Pinaki & Associates LLC Certified Public Accountant 625 Barksdale Rd, Ste# 113 Newark, DE 19711 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EX-14.1 6 exh141.htm EXHIBIT 14.1 Exhibit 14.1 Pinaki & Associates LLC Certified Public Accountant 625 Barksdale Rd, Ste# 113 Newark, DE 19711 510-274-5471 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use of our report dated April 11, 2016 with respect to the consolidated statements of financial position as at December 31, 2015 and 2014 and the consolidated statements
May 10, 2016	EX-12.1	Exhibit 12.1 Exhibit 12.1 Exhibit 12.1 CERTIFICATION I, David K. Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
May 10, 2016	EX-12.2	Exhibit 12.2 Exhibit 12.2 Exhibit 12.2 CERTIFICATION I, David K. Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
April 15, 2016	6-K/A	Genoil GENOIL INC. 6-K/A (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Amendment No. 1 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2016 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of princi
April 15, 2016	EX-99.2	Pinaki & Associates LLC Certified Public Accountants 625 Barksdale Rd., Ste# 113 Newark, DE 19711 Phone: 408-896-4405 \| [email protected] INDEPENDENT AUDITOR'S REPORT Exhibit 99.2 Pinaki & Associates LLC Certified Public Accountants 625 Barksdale Rd., Ste# 113 Newark, DE 19711 Phone: 408-896-4405 \| [email protected] INDEPENDENT AUDITOR'S REPORT To The Board of Directors Genoil Inc One Rockefeller Center, 11 th Floor New York, NY 10020 We have audited the accompanying financial statements of Genoil Inc. which comprise the balance sheet as at Decemb
April 15, 2016	EX-99.1	Management's Discussion and Analysis December 31, 2015 Exhibit 99.1 Management's Discussion and Analysis December 31, 2015 Management's Discussion and Analysis Dated as of April 12, 2016 This Management's Discussion and Analysis (MD&A) is dated April 12, 2016, and should be read in conjunction with the audited financial statements for the year ended December 31, 2015. This and other information relating to Genoil Inc. are available on SEDAR at www.sed
April 14, 2016	EX-99.2	Pinaki & Associates LLC Certified Public Accountants 625 Barksdale Rd., Ste# 113 Newark, DE 19711 Phone: 408-896-4405 \| [email protected] INDEPENDENT AUDITOR'S REPORT Exhibit 99.2 Pinaki & Associates LLC Certified Public Accountants 625 Barksdale Rd., Ste# 113 Newark, DE 19711 Phone: 408-896-4405 \| [email protected] INDEPENDENT AUDITOR'S REPORT To The Board of Directors Genoil Inc One Rockefeller Center, 11 th Floor New York, NY 10020 We have audited the accompanying financial statements of Genoil Inc. which comprise the balance sheet as at Decemb
April 14, 2016	6-K	Genoil GENOIL INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2016 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executive offi
April 14, 2016	EX-99.1	Management's Discussion and Analysis December 31, 2015 Exhibit 99.1 Management's Discussion and Analysis December 31, 2015 Management's Discussion and Analysis Dated as of April 12, 2016 This Management's Discussion and Analysis (MD&A) is dated April 12, 2016, and should be read in conjunction with the audited financial statements for the year ended December 31, 2015. This and other information relating to Genoil Inc. are available on SEDAR at www.sed
January 19, 2016	EX-12.1	Exhibit 12.1 Exhibit 12.1 Exhibit 12.1 CERTIFICATION I, David K. Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
January 19, 2016	EX-14.1	Pinaki & Associates LLC Certified Public Accountant 625 Barksdale Rd, Ste# 113 Newark, DE 19711 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 14.1 Pinaki & Associates LLC Certified Public Accountant 625 Barksdale Rd, Ste# 113 Newark, DE 19711 510-274-5471 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use of our report dated May 2, 2015 with respect to the consolidated statements of financial position as at December 31, 2014 and 2013 and the consolidated statements of loss and comprehensive loss, chan
January 19, 2016	20-F	Genoil GENOIL INC. 20-F OMB APPROVAL UNITED STATES OMB Number 3235-0288 SECURITIES AND EXCHANGE COMMISSION Expires: May 31, 2016 WASHINGTON, D.
January 19, 2016	EX-13.1	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 13.1 Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F of Genoil Inc. (the "Company") for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David K. Lifschultz, Chairman and Chief Executi
January 19, 2016	EX-13.2	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 13.2 Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F of Genoil Inc. (the "Company") for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Brian Korney, Chief Financial Officer of the Co
January 19, 2016	EX-12.2	Exhibit 12.2 Exhibit 12.2 Exhibit 12.2 CERTIFICATION I, David K. Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
December 14, 2015	EX-99.1	Consolidated Financial Statements March 31, 2015 and 2014 EX-99.1 2 exh991.htm EXHIBIT 99.1 Exhibit 99.1 Consolidated Financial Statements March 31, 2015 and 2014 GENOIL, INC. Consolidated Balance Sheets ASSETS March 31, December 31, 2015 2014 (Unaudited) CURRENT ASSETS Cash and cash equivalents $ - $ - Prepaid expenses and deposits 679 679 Due from related-parties 316,606 262,495 Total Current Assets 317,285 263,174 PROPERTY AND EQUIPMENT, net 73,632 77
December 14, 2015	6-K	Genoil GENOIL INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2014 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executive o
December 14, 2015	6-K	Genoil (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2015 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executive
December 14, 2015	6-K	Genoil GENOIL 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2015 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executive offi
December 14, 2015	6-K	Genoil GENOIL INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2014 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executive o
December 14, 2015	EX-99.1	Consolidated Financial Statements September 30, 2015 and 2014 Exhibit 99.1 Consolidated Financial Statements September 30, 2015 and 2014 GENOIL, INC. Consolidated Balance Sheets ASSETS September 30, December 31, 2015 2014 (Unaudited) CURRENT ASSETS Cash and cash equivalents $ - $ - Prepaid expenses and deposits 679 679 Due from related-parties 434,906 262,495 Total Current Assets 435,585 263,174 PROPERTY AND EQUIPMENT, net 87,844 77,564 OTHER ASSETS Intangib
December 14, 2015	EX-99.1	Consolidated Financial Statements December 31, 2014 and 2013 Exhibit 99.1 Consolidated Financial Statements December 31, 2014 and 2013 Management's Responsibility To the Shareholders of Genoil Inc. (the "Company"): Management is responsible for the preparation and presentation of the accompanying consolidated financial statements, including responsibility for significant accounting judgments and estimates in accordance with International Financial Reporting
December 14, 2015	EX-99.1	FOR: GENOIL INC. Exhibit 99.1 NEWS RELEASE TRANSMITTED BY MARKETWIRED FOR: GENOIL INC. OTCBB SYMBOL: GNOLF December 14, 2015 Genoil Completes 2013 & 2014 Audited Financials & Three 2015 Quarterly's, Raises $622,000 USD in a Non Brokered Private Placement, and Is Moving Forward on Its Residue Upgrading Refinery in China CALGARY, ALBERTA-(Marketwired - Dec. 14, 2015) - Genoil (OTCBB:GNOLF) announces that it has rece
December 14, 2015	EX-99.1	Consolidated Financial Statements December 31, 2014 and 2013 EX-99.1 2 exh991.htm EXHIBIT 99.1 Exhibit 99.1 Consolidated Financial Statements December 31, 2014 and 2013 Management's Responsibility To the Shareholders of Genoil Inc. (the "Company"): Management is responsible for the preparation and presentation of the accompanying consolidated financial statements, including responsibility for significant accounting judgments and estimates in accordance with
December 14, 2015	6-K	Genoil GENOIL INC. 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2014 Commission File Number 000-50766 GENOIL INC. (Translation of registrant's name into English) One Rockefeller Plaza 11th Floor New York, NY 20020 (Address of principal executive o
December 14, 2015	EX-99.2	Management's Discussion and Analysis December 31, 2014 Exhibit 99.2 Management's Discussion and Analysis December 31, 2014 Management's Discussion and Analysis Dated as of December 11, 2015 This Management's Discussion and Analysis (MD&A) is dated December 11, 2015, and should be read in conjunction with the audited financial statements for the year ended December 31, 2014. This and other information relating to Genoil Inc. are available on SEDAR at w
December 14, 2015	EX-99.4	Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate Exhibit 99.4 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, David Lifschultz, Chief Financial Officer and Acting Chief Financial Officer of Genoil Inc., certify the following in my capacity as Acting Chief Financial Officer: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents an
December 14, 2015	EX-99.3	Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate Exhibit 99.3 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, David Lifschultz, Chief Executive Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the " annual
December 14, 2015	EX-99.2	Management's Discussion and Analysis December 31, 2014 EX-99.2 3 exh992.htm EXHIBIT 99.2 Exhibit 99.2 Management's Discussion and Analysis December 31, 2014 Management's Discussion and Analysis Dated as of December 11, 2015 This Management's Discussion and Analysis (MD&A) is dated December 11, 2015, and should be read in conjunction with the audited financial statements for the year ended December 31, 2014. This and other information relating to Genoi
December 14, 2015	EX-99.4	Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate Exhibit 99.4 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, David Lifschultz, Chief Financial Officer and Acting Chief Financial Officer of Genoil Inc., certify the following in my capacity as Acting Chief Financial Officer: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents an
December 14, 2015	EX-99.3	Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate EX-99.3 4 exh993.htm EXHIBIT 99.3 Exhibit 99.3 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, David Lifschultz, Chief Executive Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference i
December 10, 2015	20-F	Genoil GENOIL INC. 20-F OMB APPROVAL UNITED STATES OMB Number 3235-0288 SECURITIES AND EXCHANGE COMMISSION Expires: May 31, 2016 WASHINGTON, D.
November 4, 2015	EX-99.3	Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate Exhibit 99.3 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, David Lifschultz, Chief Executive Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the "annual f
November 4, 2015	EX-99.1	Consolidated Financial Statements December 31, 2013 and 2012 Management's Responsibility To the Shareholders of Genoil Inc. (the "Company"): Management is responsible for the preparation and presentation of the accompanying consolidated financial sta Exhibit 99.1 Consolidated Financial Statements December 31, 2013 and 2012 Management's Responsibility To the Shareholders of Genoil Inc. (the "Company"): Management is responsible for the preparation and presentation of the accompanying consolidated financial statements, including responsibility for significant accounting judgments and estimates in accordance with International Financial Reporting
November 4, 2015	EX-99.2	Management's Discussion and Analysis December 31, 2013 Exhibit 99.2 Management's Discussion and Analysis December 31, 2013 Management's Discussion and Analysis Dated as of November 3, 2015 This Management's Discussion and Analysis (MD&A) is dated November 3, 2015, and should be read in conjunction with the audited financial statements for the year ended December 31, 2013. This and other information relating to Genoil Inc. are available on SEDAR at www
November 4, 2015	6-K	Genoil GENOIL INC. 6-K (Current Report of Foreign Issuer) OMB APPROVAL OMB Number: 3235-0116 Expires: March 31, 2014 UNITED STATES Estimated average burden hours per response 8.
November 4, 2015	EX-99.4	Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate EX-99.4 5 exh994.htm EXHIBIT 99.4 Exhibit 99.4 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, David Lifschultz, Chief Financial Officer and Acting Chief Financial Officer of Genoil Inc., certify the following in my capacity as Acting Chief Financial Officer: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for g
December 3, 2013	6-K	Current Report of Foreign Issuer - FORM 6K Filed by e3 Filing, Computershare 1-800-973-3274 - Genoil Inc. - Form 6-K OMB APPROVAL OMB Number: 3235-0116 Expires: March 31, 2014 UNITED STATES Estimated average burden hours per response 8.7 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 20
December 3, 2013	EX-1	Interim Condensed Consolidated Financial Statements, September 30, 2013 (Unaudited) Exhibit 99.1 Exhibit 99.1 Interim Condensed Consolidated Financial Statements September 30, 2013 (Unaudited) November 29, 2013 Management's Responsibility for Financial Reporting The accompanying unaudited interim condensed consolidated financial statements of Genoil Inc. (the “Corporation”) were prepared by management in accordance with International Financial Reporting Standards. Management ackn
December 3, 2013	EX-3	Certification of Interim Filings - CEO and CFO Exhibit 99.3 Exhibit 99.3 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, David Lifschultz (i) the certifying officer, Chief Financial Officer & CEO (iii) Genoil Inc, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Genoil Inc (the “issuer”) for the interim period ended September
December 3, 2013	EX-2	Management's Discussion and Analysis, September 30, 2013 Exhibit 99.2 Exhibit 99.2 Management’s Discussion and Analysis September 30, 2013 1 Management’s Discussion and Analysis Dated as of September 27, 2013 INTRODUCTION The following Management Discussion and Analysis (“MD&A”) is management’s assessment of Genoil Inc.’s financial and operating results and should be read in conjunction with the unaudited interim condensed consolidated financial stateme
August 28, 2013	EX-3	FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE ceocertq22013.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, David Lifschultz, the Chief Executive Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Genoil Inc. (the “issuer
August 28, 2013	EX-1	Interim Condensed Consolidated Financial Statements June 30, 2013 q2fsandnotesfinal.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Interim Condensed Consolidated Financial Statements June 30, 2013 (unaudited) August 27, 2013 Management's Responsibility for Financial Reporting The accompanying unaudited interim condensed consolidated financial statements of Genoil Inc. (the “Corporation”) were prepared by management in accordan
August 28, 2013	EX-4	FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE cfocertq22013.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Brian Korney, the Chief Financial Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Genoil Inc. (the “issuer”) f
August 28, 2013	6-K	Current Report of Foreign Issuer - FORM 6K form6-kq22013.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing OMB APPROVAL OMB Number: 3235-0116 Expires: March 31, 2014 Estimated average burden hours UNITED STATES per response. 8.7 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For t
August 28, 2013	EX-2	Management’s Discussion and Analysis mda2013q2final.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Management’s Discussion and Analysis June 30, 2013 1 Management’s Discussion and Analysis Dated as of August 27, 2013 INTRODUCTION The following Management Discussion and Analysis (“MD&A”) is management’s assessment of Genoil Inc.’s financial and operating results and should be read in conjunction wit
May 31, 2013	EX-4	Brian Korney, EX-4 7 cfocertq12013.htm Q1 2013 CFO CERT FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Brian Korney, the Chief Financial Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Genoil Inc. (the “issuer”) for the interim period ended March 31, 2013. 2. No misre
May 31, 2013	EX-1	Interim Condensed Consolidated Financial Statements q1fsandnotesfinal.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Interim Condensed Consolidated Financial Statements March 31, 2013 (unaudited) May 30th, 2013 Management's Responsibility for Financial Reporting The accompanying unaudited interim condensed consolidated financial statements of Genoil Inc.(the “Corporation”) were prepared by management in accordanc
May 31, 2013	EX-3	David Lifschultz, ceocertq12013.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, David Lifschultz, the Chief Executive Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Genoil Inc. (the “issuer
May 31, 2013	6-K	Current Report of Foreign Issuer - FORM 6-K form6-kq12013.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing OMB APPROVAL OMB Number: 3235-0116 Expires: March 31, 2014 Estimated average burden hours per response. 8.7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For t
May 31, 2013	EX-2	Management’s Discussion and Analysis EX-2 4 mda2013q1final.htm Q1 2013 MD&A Management’s Discussion and Analysis March 31, 2013 1 Management’s Discussion and Analysis Dated as of May 30, 2013 INTRODUCTION The following Management Discussion and Analysis (“MD&A”) is management’s assessment of Genoil Inc.’s financial and operating results and should be read in conjunction with the unaudited interim condensed consolidated financial stat
May 7, 2013	EX-4	(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is mad cfo2012certificates.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Exhibit 12.2 CERTIFICATION I, Brian Korney, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in li
May 7, 2013	EX-1	See accompanying notes to consolidated financial statements. genoilfinancialstatements.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Management’s Responsibility To the Shareholders of Genoil Inc.: Management is responsible for the preparation and presentation of the accompanying consolidated financial statements, including responsibility for significant accounting judgments and estimates in accordance with International
May 7, 2013	EX-7	Convertible Promissory Notes Dated October 6, 2011 with Lifschultz Enterprises Co, LLC, Sidney B. Lifschultz 1992 Family Trust, David K Lifschultz and Bruce Abbott notesextension.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing
May 7, 2013	EX-3	In connection with the Annual Report on Form 20- Exhibit 12.1 CERTIFICATION I, David K. Lifschultz, certify that: 1. I have reviewed this annual report on Form 20-F of Genoil Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to t
May 7, 2013	20-F	- finalform20f.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing OMB APPROVAL UNITED STATES OMB Number: 3235-0288 SECURITIES AND EXCHANGE COMMISSION Expires: April 30, 2015 WASHINGTON, D.C. 20549 Estimated average burden hours per response…2645.52 FORM 20-F (Mark One) REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR X
May 7, 2013	EX-2	Management’s Discussion and Analysis Management’s Discussion and Analysis December 31, 2012 1 Management’s Discussion and Analysis Dated as of April 30, 2013 INTRODUCTION The following Management Discussion and Analysis (“MD&A”) is management’s assessment of Genoil Inc.
February 28, 2013	CORRESP	- refilingcover.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Suite 1580, 727 – 7th Avenue SW Calgary, Alberta T2P 0Z5, Canada Tel: (403) 750-3450 Fax: (403) 290-0592 Consolidated Financial Statements for the year ended December 31, 2011 These financial statements are being re-filed on the current date because: 1. Note 2(a) has been revised to disclose that the f
February 28, 2013	EX-1	INDEPENDENT AUDITORS’ REPORT OF REGISTERED PUBLIC ACCOUNTING FIRM restated2011finalfinstmt.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing The consolidated financial statements of the Company for the year ended December 31, 2011, together with the Independent Auditors’ Report of Registered Public Accounting Firm, are being re-filed to make certain non-material clarification changes, specifically, adding the following wording af
February 28, 2013	20-F	- amended2012form20f.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing OMB APPROVAL UNITED STATES OMB Number: 3235-0288 SECURITIES AND EXCHANGE COMMISSION Expires: May 31, 2014 WASHINGTON, D.C. 20549 Estimated average burden hours per response…2645.00 AMENDED FORM 20-F (Mark One) REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT O
November 30, 2012	EX-4	Brian Korney, the Chief Financial Officer of Genoil Inc. EX-4 7 cfocertinterimq3.htm Q3 CFO CERT FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Brian Korney, the Chief Financial Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the “interim filings”) of Genoil Inc. (the “issuer”) for the interim period ended September 30, 2012. 2. No misrepresentatio
November 30, 2012	6-K	Current Report of Foreign Issuer - FORM 6-K form6-kq32012.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing OMB APPROVAL OMB Number: 3235-0116 Expires: March 31, 2014 Estimated average burden hours UNITED STATES per response. 8.7 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For t
November 30, 2012	EX-1	See accompanying notes to interim condensed consolidated financial statements. q3fsandnotesfinal.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Interim Condensed Consolidated Financial Statements September 30, 2012 (unaudited) Notice of No Auditor Review of Interim Condensed Consolidated Financial Statements In accordance with National Instrument 51-102 released by the Canadian Securities Administrators, the Company discloses that its audi
November 30, 2012	EX-2	Management’s Discussion and Analysis EX-2 4 mda2012q3final.htm Q3 2012 MD&A Management’s Discussion and Analysis September 30, 2012 1 Management’s Discussion and Analysis Dated as of November 28, 2012 INTRODUCTION The following Management Discussion and Analysis (“MD&A”) is management’s assessment of Genoil Inc.’s financial and operating results and should be read in conjunction with the unaudited interim condensed consolidated finan
November 30, 2012	EX-3	David K. Lifschultz, the Chief Executive Officer of Genoil Inc. ceocertinterimq3.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, David K. Lifschultz, the Chief Executive Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the “interim filings”) of Genoil Inc. (the “issuer”) for
August 28, 2012	EX-4	Brian Korney, the Chief Financial Officer of Genoil Inc. cfocertinterimq2.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Brian Korney, the Chief Financial Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the “interim filings”) of Genoil Inc. (the “issuer”) for the int
August 28, 2012	EX-1	See accompanying notes to interim condensed consolidated financial statements. q2fsandnotesfinal.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Interim Condensed Consolidated Financial Statements June 30, 2012 (unaudited) Notice of No Auditor Review of Interim Condensed Consolidated Financial Statements In accordance with National Instrument 51-102 released by the Canadian Securities Administrators, the Company discloses that its auditors
August 28, 2012	EX-2	Management’s Discussion and Analysis mda2012q2final.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing Management’s Discussion and Analysis June 30, 2012 1 Management’s Discussion and Analysis Dated as of August 28, 2012, 2012 INTRODUCTION The following Management Discussion and Analysis (“MD&A”) is management’s assessment of Genoil Inc.’s financial and operating results and should be read in conjuncti
August 28, 2012	EX-3	David K. Lifschultz, the Chief Executive Officer of Genoil Inc. ceocertinterimq2.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, David K. Lifschultz, the Chief Executive Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the “interim filings”) of Genoil Inc. (the “issuer”) for
August 28, 2012	6-K	Current Report of Foreign Issuer - form6-kq22012.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing OMB APPROVAL OMB Number: 3235-0116 Expires: March 31, 2014 Estimated average burden hours UNITED STATES per response. 8.7 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For t
June 5, 2012	EX-3	David K. Lifschultz, the Chief Executive Officer of Genoil Inc. ceocertinterimq1.htm - Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, David K. Lifschultz, the Chief Executive Officer of Genoil Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the “interim filings”) of Genoil Inc. (the “issuer”) for

GNOLF / Genoil Inc. - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

Grundläggande statistik

SEC Filings

SEC Filings (Chronological Order)